• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

    3.475 -0.045 (-1.28%)
    Streaming Delayed Price Updated: 3:25 PM EDT, May 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Iovance Biotherapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    23 24 Next >
    News headline image
    Iovance Biotherapeutics to Present at Upcoming Conferences
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today ↗
    The company hasn't been popular among investors since winning its first FDA approval more than a year ago. 
    Via The Motley Fool
    News headline image
    Why Iovance Biotherapeutics Stock Got Mashed on Monday ↗
    The company announced a flotation of its common shares that is potentially quite dilutive. 
    Via The Motley Fool
    News headline image
    Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗
     
    Via Benzinga
    Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’ ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
     
    Via Benzinga
    News headline image
    1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street ↗
    Time is running out for the company to mount a comeback. 
    Via The Motley Fool
    News headline image
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Iovance Biotherapeutics Stock Was Climbing Today ↗
    One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country. 
    Via The Motley Fool
    News headline image
    Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    News headline image
    Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    3 Stocks That Could Turn $1,000 Into $5,000 by 2030 ↗
    All three of these companies are entering a period of what could produce unparalleled top- and bottom-line growth. 
    Via The Motley Fool
    News headline image
    Why Iovance Biotherapeutics Stock Plummeted Today ↗
    The company's top line nearly doubled. 
    Via The Motley Fool
    News headline image
    What 7 Analyst Ratings Have To Say About Iovance Biotherapeutics ↗
     
    Via Benzinga
    News headline image
    Pinterest Posts Downbeat Q2 Earnings, Joins Twilio, Trade Desk And Other Big Stocks Moving Lower In Friday Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Which stocks are moving before the opening bell on Friday? ↗
    Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening ↗
    Iovance stock fell over 29% pre-market after Q2 results, despite reporting a strong revenue jump led by Amtagvi sales. 
    Via Benzinga
    News headline image
    Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    Iovance (IOVA) Q2 Revenue Jumps 93% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Is Iovance Biotherapeutics Stock Due for a Big Rally? ↗
    The biotech stock has been picking up steam of late -- but will it last? 
    Via The Motley Fool
    News headline image
    This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy? ↗
    Even the average price estimate for this stock suggests it can soar, but not everyone's convinced. 
    Via The Motley Fool
    News headline image
    Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    23 24 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.